Search

Your search keyword '"Crozier, Ian"' showing total 798 results

Search Constraints

Start Over You searched for: Author "Crozier, Ian" Remove constraint Author: "Crozier, Ian"
798 results on '"Crozier, Ian"'

Search Results

1. Ophthalmic Sequelae of Ebola Virus Disease in Survivors, Sierra Leone

2. A Lassa virus live attenuated vaccine candidate that is safe and efficacious in guinea pigs

6. Fatal meningoencephalitis associated with Ebola virus persistence in two survivors of Ebola virus disease in the Democratic Republic of the Congo: a case report study

10. 2021 Taxonomic update of phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales

11. Ebola Virus Transmission Initiated by Relapse of Systemic Ebola Virus Disease

13. Natural history of Ebola virus disease in rhesus monkeys shows viral variant emergence dynamics and tissue-specific host responses

14. Depletion of Bone Marrow Hematopoietic Cells in Ebolavirus-Infected Rhesus Macaques: A Possible Cause of Hematologic Abnormalities in Ebolavirus Disease

16. 2020 taxonomic update for phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales

17. Deep-Learning-Based Whole-Lung and Lung-Lesion Quantification Despite Inconsistent Ground Truth: Application to Computerized Tomography in SARS-CoV-2 Nonhuman Primate Models

18. Rationale and design for the myocardial ischemia and transfusion (MINT) randomized clinical trial

20. Effects of therapies for Ebola virus disease: a systematic review and network meta-analysis

21. Anti-Ebola virus mAb 3A6 protects highly viremic animals from fatal outcome via binding GP(1,2) in a position elevated from the virion membrane.

23. Asymmetric and non-stoichiometric glycoprotein recognition by two distinct antibodies results in broad protection against ebolaviruses

25. Medical imaging of pulmonary disease in SARS-CoV-2-exposed non-human primates

28. Correction to: 2021 Taxonomic update of phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales

30. Long-term visual outcomes and histopathologic findings after cataract surgery in Ebola virus disease survivors in the Ebola virus RNA persistence in ocular tissues and fluids (EVICT) study.

32. Screening for Eye Disease in Ebola Virus Disease Survivors: Program Implementation During an Active Outbreak in the North Kivu and Ituri Provinces, Democratic Republic of the Congo.

33. Establishing Vitreoretinal Surgery Capacity in Sierra Leone: Challenges and Opportunities to Address Retinal Health Disparities in Resource-limited Settings.

35. Clinical grade ACE2 as a universal agent to block SARS‐CoV‐2 variants

36. Recent successes in therapeutics for Ebola virus disease: no time for complacency

40. Lung lesion segmentation of CT scans after SARS-CoV-2 infection: combining nonhuman primate with human data for inter-species transfer learning

42. A safe and efficacious Lassa virus live-attenuated vaccine candidate based on rearrangement of the intergenic region and codon-deoptimization of the glycoprotein gene

43. Animal models for COVID-19

44. Longitudinal Analysis of the Human B Cell Response to Ebola Virus Infection

46. “Piece by Piece” understanding of patient reported QOL and EV‐ICD: Response to letter from Vicentini and Rodorf

47. Patient reported QOL and EV‐ICD: Response to letter from Kataoka and Imamura (2024)

48. Comprehensive analysis of substernal lead removal: experience from EV ICD Pilot, Pivotal, and Continued Access Studies.

50. Identification of Combinations of Approved Drugs With Synergistic Activity Against Ebola Virus in Cell Cultures

Catalog

Books, media, physical & digital resources